A Meta-Analysis to Assess the Efficacy of HER2-Targeted Treatment Regimens in HER2-Positive Metastatic Colorectal Cancer (mCRC)

Recent trials provide evidence that HER2 is a potential new target for patients with colorectal cancer. While HER2-positive tumors do not show a very encouraging response to anti-HER2-positive agents like trastuzumab alone, promising results have been observed when combined with other synergisticall...

Descripción completa

Detalles Bibliográficos
Autores principales: Chitkara, Akshit, Bakhtiar, Muhammad, Sahin, Ibrahim Halil, Hsu, Dennis, Zhang, Janie, Anamika, FNU, Mahnoor, Mahnoor, Ahmed, Rabeea, Gholami, Sepideh, Saeed, Anwaar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528053/
https://www.ncbi.nlm.nih.gov/pubmed/37754515
http://dx.doi.org/10.3390/curroncol30090600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528053/
https://www.ncbi.nlm.nih.gov/pubmed/37754515
http://dx.doi.org/10.3390/curroncol30090600

Ejemplares similares